Veracyte to Acquire HalioDx, Solidifying Global Leadership in Cancer Diagnostics     Learn More
Veracyte to Acquire HalioDx, Solidifying Global Leadership in Cancer Diagnostics     Learn More
Skip to content
10-Q

SEC Filing Details

Document Details

Form
Filing Date
May 10, 2021
Document Date
Mar 31, 2021
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Veracyte, Inc.
Issuer
VERACYTE, INC.